Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases

2020146 citationsJournal Articlebronze Open Access

Authors

In type 2 diabetes, treatment with SGLT2i or GLP-1 compared with DPP-4 or sulfonylureas was associated with a lower risk of adverse kidney outcomes.

Good health and well-being

Published in: Diabetes Care

Volume 43, Issue 11, pp. 2859-2869

Field-Weighted Citation Impact: 10.94